Corundum Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.27M Buy
1,629
+584
+56% +$455K 0.56% 43
2025
Q1
$863K Sell
1,045
-1,673
-62% -$1.38M 0.41% 58
2024
Q4
$2.1M Buy
2,718
+1,656
+156% +$1.28M 0.78% 31
2024
Q3
$941K Sell
1,062
-2,867
-73% -$2.54M 0.43% 55
2024
Q2
$3.56M Buy
3,929
+2,427
+162% +$2.2M 1.39% 18
2024
Q1
$1.17M Sell
1,502
-64
-4% -$49.8K 0.56% 40
2023
Q4
$913K Buy
1,566
+8
+0.5% +$4.66K 0.46% 50
2023
Q3
$837K Sell
1,558
-462
-23% -$248K 0.48% 48
2023
Q2
$947K Sell
2,020
-2,474
-55% -$1.16M 0.47% 54
2023
Q1
$1.54M Buy
4,494
+2,320
+107% +$797K 0.73% 42
2022
Q4
$795K Buy
2,174
+49
+2% +$17.9K 0.45% 58
2022
Q3
$687K Buy
2,125
+88
+4% +$28.5K 0.43% 60
2022
Q2
$660K Buy
2,037
+59
+3% +$19.1K 0.45% 58
2022
Q1
$566K Buy
1,978
+153
+8% +$43.8K 0.53% 71
2021
Q4
$504K Buy
1,825
+80
+5% +$22.1K 0.33% 58
2021
Q3
$403K Buy
1,745
+114
+7% +$26.3K 0.3% 58
2021
Q2
$374K Sell
1,631
-151
-8% -$34.6K 0.25% 61
2021
Q1
$333K Buy
1,782
+16
+0.9% +$2.99K 0.26% 63
2020
Q4
$298K Buy
1,766
+140
+9% +$23.6K 0.25% 66
2020
Q3
$241K Buy
1,626
+59
+4% +$8.75K 0.23% 67
2020
Q2
$257K Sell
1,567
-215
-12% -$35.3K 0.31% 41
2020
Q1
$247K Sell
1,782
-139
-7% -$19.3K 0.35% 40
2019
Q4
$252K Buy
1,921
+87
+5% +$11.4K 0.26% 59
2019
Q3
$205K Sell
1,834
-2
-0.1% -$224 0.24% 61
2019
Q2
$203K Buy
1,836
+14
+0.8% +$1.55K 0.23% 65
2019
Q1
$236K Sell
1,822
-4,154
-70% -$538K 0.27% 51
2018
Q4
$692K Buy
+5,976
New +$692K 0.64% 28